WE COULD SOON SEE A NEW TOOL TO FIGHT A DEADLY FORM OF BRAIN CANCER THAT’S BEEN IMMUNE TO RADIATION AND OTHER CONVENTIONAL TREATMENTS. AND IT’S THANKS TO CLINICAL TRIALS BEING CONDUCTED AT UNM’S CANCER CENTER. THE ALBUQUERQUE JOURNAL REPORTS THIS COULD TREAT GLIOBLASTOMAS, WHICH IS THE BRAIN CANCER ARIZONA SENATOR JOHN MCCAIN SUFFERS FROM. IF OTHER TREATMENTS DON’T WORK FOR HIM, MCCAIN COULD END UP AT UNM FOR TREATMENT.
PHASE ONE TRIALS FOR THE DRUG BXQ-350 WERE FOUND IN PRE-CLINICAL STUDIES TO INDUCE CANCER CELLS TO DIE BUT TO HAVE LITTLE IMPACT ON NORMAL CELLS. IT’S ONE OF A DOZEN PHASE ONE CLINICAL TRIALS STARTED AT UNM’S CANCER CENTER.
